GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Paion Ag (LTS:0NF3) » Definitions » Beginning Cash Position

Paion Ag (LTS:0NF3) Beginning Cash Position : €10.63 Mil (As of Jun. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Paion Ag Beginning Cash Position?

Paion Ag's Beginning Cash Position for the quarter that ended in Jun. 2023 was €10.63 Mil.

Paion Ag's quarterly Beginning Cash Position declined from Jun. 2022 (€6.44 Mil) to Dec. 2022 (€0.00 Mil) but then increased from Dec. 2022 (€0.00 Mil) to Jun. 2023 (€10.63 Mil).

Paion Ag's annual Beginning Cash Position increased from Dec. 2020 (€18.79 Mil) to Dec. 2021 (€19.67 Mil) but then declined from Dec. 2021 (€19.67 Mil) to Dec. 2022 (€6.44 Mil).


Paion Ag Beginning Cash Position Historical Data

The historical data trend for Paion Ag's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paion Ag Beginning Cash Position Chart

Paion Ag Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.84 17.23 18.79 19.67 6.44

Paion Ag Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.67 - 6.44 - 10.63

Paion Ag Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.


Paion Ag Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Paion Ag's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Paion Ag (LTS:0NF3) Business Description

Traded in Other Exchanges
Address
Heussstrasse 25, Aachen, DEU, 52078
Paion Ag is a holding company engaged in providing various services to the subsidiaries. The group is focused on developing and commercializing medical innovations for procedural sedation, anesthesia, and critical care services. The key product of the company is remimazolam, which is an ultra-short-acting intravenous benzodiazepine sedative. In the human body, remimazolam is rapidly metabolized to an inactive metabolite by tissue esterases and not metabolized by cytochrome-dependent hepatic pathways. The organization is based in Germany.

Paion Ag (LTS:0NF3) Headlines

No Headlines